News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
A newer class of drugs that target pancreatic cancer may get a helping hand from an old treatment workhorse
Pancreatic cancer/X
Nov 24, 2024, 15:35

A newer class of drugs that target pancreatic cancer may get a helping hand from an old treatment workhorse

NCI Center for Cancer Research shared on LinkedIn:

” Christine Alewine, from our Laboratory of Molecular Biology, was interviewed for this article! Read more below about pancreatic cancer treatments using chemotherapy.

A newer class of drugs that target pancreatic cancer may get a helping hand from an old treatment workhorse: chemotherapy. Two new studies in mice show that adding chemotherapy to an experimental KRAS inhibitor called MRTX1133 greatly reduced tumor growth and spread compared with either treatment alone. ”

A newer class of drugs that target pancreatic cancer may get a helping hand from an old treatment workhorse

cancer Christine Alewine NCI Center for Cancer Research OncoDaily Oncology Pancreatic Cancer
Special Coverage
Blog
Apr 16, 2025, 19:01
Richard Sullivan: WHO Meeting Reflected on Cancer and IO Drug Pairs
Blog
Apr 16, 2025, 18:50
Join the Third Annual Virtual TAPUR Study Grand Rounds 2025 - ASCO
Blog
Apr 16, 2025, 18:44
The month of the Explore Your Health festival is coming to an end - IARC/WHO
Blog
Apr 16, 2025, 18:38
Why doesn't your body attack the food you eat? - Cancer Research Institute
Blog
Apr 16, 2025, 18:33
Massive Bio has officially received certification from the CNIL
Blog
Apr 16, 2025, 18:17
Peter Pisters: It was wonderful to drop by MD Anderson Cancer Center’s LEADing Leaders/LEADing Institution Training
Blog
Apr 16, 2025, 18:15
MASCC Guidance on Osteoradionecrosis in Patients with Head and Neck Cancer
Blog
Apr 16, 2025, 17:56
Study MSc Transformative Oncology from The University of Manchester online and part-time
Blog
Apr 16, 2025, 17:55
Amol Akhade: Should CDK4/6 inhibitors be standard in early HR+/HER2– breast cancer?
Blog
Apr 16, 2025, 17:46
Dégi László Csaba called for action on QoL in cancer care at EUonQol General Assembly - European Cancer Organisation
Opinion
Apr 16, 2025, 17:39
Is Cancer Hereditary? Myths and Facts about Cancer Genetics
Blog
Apr 16, 2025, 17:37
Are you working on neoadjuvant immunotherapy? - 3P Solution